MARKET

CANF

CANF

Can-Fite BioPharma Ltd.
AMEX
3.120
+0.040
+1.30%
Opening 14:13 04/09 EDT
OPEN
3.120
PREV CLOSE
3.080
HIGH
3.160
LOW
2.970
VOLUME
37.70K
TURNOVER
--
52 WEEK HIGH
36.40
52 WEEK LOW
2.950
MARKET CAP
6.68M
P/E (TTM)
-0.0017
1D
5D
1M
3M
1Y
5Y
1D
Can-Fite BioPharma director Guy Regev files initial beneficial ownership statement
Reuters · 2d ago
Weekly Report: what happened at CANF last week (0330-0403)?
Weekly Report · 3d ago
Can-Fite BioPharma files to sell 3.29M ordinary shares for holders
TipRanks · 03/31 10:16
Can-Fite and Vetbiolix Complete Phase 2 Enrollment for Canine Osteoarthritis Drug Piclidenoson
TipRanks · 03/30 12:05
Can-Fite BioPharma completes enrollment in Piclidenoson study
TipRanks · 03/30 11:37
Can-Fite Biopharma's Veterinary Partner Vetbiolix Completes Enrollment In Phase 2 Study Of Piclidenoson For Osteoarthritis In Dogs; Topline Data Are Expected In Q3 2026
Benzinga · 03/30 11:25
CAN FITE BIOPHARMA LTD - CAN-FITE SIGNS DEAL WITH VETBIOLIX WORTH UP TO $325 MLN
Reuters · 03/30 11:20
Can-Fite partner Vetbiolix completes enrollment in Phase 2 canine osteoarthritis trial of Piclidenoson
Reuters · 03/30 11:20
More
About CANF
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

Webull offers Can Fite Biopharma Ltd stock information, including AMEX: CANF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CANF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CANF stock methods without spending real money on the virtual paper trading platform.